The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats

By Pamplona Fabrício   Prediger Rui   Pandolfo Pablo   Takahashi Reinaldo  

Psychopharmacology, Vol. 188, Iss. 4, 2006-11 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Transdermal Delivery of the Synthetic Cannabinoid WIN 55,212-2: In Vitro/in Vivo Correlation

By Valiveti Satyanarayana   Hammell Dana C.   Earles D. Caroline   Stinchcomb Audra L.  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1137-1145

Springer Publishing Company

Access to resources Recommend Favorite

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices

By Gifford A.N.   Samiian L.   Gatley S.J.   Ashby Jr. C.R.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 187-192

Elsevier

Access to resources Recommend Favorite

Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice

By  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 12, 2014-01 ,pp. : 975-983

NRC Research Press

Access to resources Recommend Favorite

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs

By Stengel P.W.   Rippy M.K.   Cockerham S.L.   Devane W.A.   Silbaugh S.A.  

European Journal of Pharmacology, Vol. 355, Iss. 1, 1998-08 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite